Detalhe da pesquisa
1.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248424
2.
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project.
Clin Exp Metastasis
; 2024 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38850317
3.
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).
Target Oncol
; 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704759
4.
A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC).
Clin Genitourin Cancer
; 20(5): 391-398, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595632
5.
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.
Crit Rev Oncol Hematol
; 176: 103731, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718065
6.
The role of 68Gallium-prostate-specific membrane antigen positron emission tomography on staging of high-risk localized prostate cancer: for all high-risk patients or would it be better to select them?
Prostate Int
; 9(1): 54-59, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912515
7.
Erdafitinib treatment in Brazilian patients with metastatic urothelial carcinoma (mUC): real-world evidence from an Expanded Access Program.
Ther Adv Med Oncol
; 13: 17588359211015499, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046088
8.
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis.
Clin Genitourin Cancer
; 18(4): 244-251.e4, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303427